Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.49 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.49 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL493020 | 0.87 | CYP1A2 (0.56) | CHRNB2CHRNA4CHRM2CHRM1CHRM3 | |
| Hydrochloric Acid SCHEMBL27794086 | 0.85 | CYP1A2 (0.54) | CHRNB2CHRNA4CHRM2CHRM1CHRM3 | |
| SCHEMBL29469530 | 0.85 | HSD11B1 (0.47) | CHRNB2CHRNA4CHRM2CHRM1CHRM3 | |
| SCHEMBL146442 | 0.85 | HSD11B1 (0.47) | CHRNB2CHRNA4CHRM2CHRM1CHRM3 | |
| SCHEMBL13630753 | 0.83 | CYP1A2 (0.52) | CHRNB2CHRNA4CHRM2CHRM1CHRM3 | |
| SCHEMBL16215605 | 0.80 | CHRNB2 (0.49) | CHRNB2CHRNA4CHRM2CHRM1CHRM3 | |
| SCHEMBL774717 | 0.80 | CHRNB2 (0.52) | CHRNB2CHRNA4CHRM2CHRM1CHRM3 | |
| SCHEMBL4726906 | 0.80 | CHRNB2 (0.49) | CHRNB2CHRNA4CHRM2CHRM1CHRM3 | |
| SCHEMBL9627390 | 0.80 | CHRNB2 (0.49) | CHRNB2CHRNA4CHRM2CHRM1CHRM3 | |
| SCHEMBL12417092 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612097-B2 | Method for producing bactericidal pyridine compound and bactericidal pyridine compound | TAMA KAGAKU KOGYO CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20070099961-A1 | Method for producing bactericidal pyridine compound and bactericidal pyridine compound | Kourai, Hiroki (JP) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099961-A1 | Method for producing bactericidal pyridine compound and bactericidal pyridine compound | BLVRB, CBR3, TLR7 | CHRNB2 4084/4885CHRNA4 4153/4885CHRM2 959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.